135.018 Pertussis and Cocooning

135.018

Pertussis and Cocooning: The Texas Medical Association (1) actively promote the CDC’s Advisory Committee on Immunization Practices recommendations on the use of the tetanus-diphtheria-acelluar pertussis (Tdap) vaccine, and provide education and assistance to physicians with strategies for implementing pertussis vaccination in various settings, which includes providing tools to promote Tdap for postpartum women and their families, as well as the use of Tdap in emergency departments; (2) support increased physician awareness regarding payment for diphtheria-tetanus-pertussis (DTaP) and Tdap vaccine under health insurance plans; (3) work with DSHS and local public health agencies to ensure current infectious disease data, guidance on responding to disease outbreaks, and physician-focused materials are disseminated to physicians (TMA can work with stakeholders to encourage information sharing among public health agencies, hospitals, and health care professionals); (4) work with DSHS on reviewing Texas notifiable condition requirements and recommending enhancements to support improved surveillance of pertussis deaths among infants; and (5) advocate for the allocation of additional DSHS resources for Tdap vaccine that will assist local health departments during outbreaks (CM-CID Rep. 1-A-11).

Last Updated On

October 07, 2016